CMO: A rising star
How do you handle this throughout your teams? If you want sustainable growth in this ever-increasing collaboration model, you must prepare to eliminate legacy siloed processes in favor of one single source of truth that can provide the transparency, visibility and data you need to grow with the fierce competition you face.
Predications estimate that CMO market value will reach $205 billion by the year 2027
The contract manufacturing organizations (CMO) or contract development manufacturing organizations (CDMO) market is on the rise due to increasing drug R&D costs.
As a means to remaining competitive and optimizing the “total cost of ownership” associated with developing, manufacturing and commercialization of products, these companies focus on not just the function but also the value of outsourced partnerships and strategic collaborations. If you’re one of them, you have a great deal to manage.
The most significant determinant in the move to a CMO/CDMO collaboration is the need by pharma to direct their priorities toward their core areas of competency and outsource to a CMO for expertise, resources and technology in production capability and regulatory requirements.
When it comes to managing these collaborations, you must keep in mind that both partners need to strategize and manage not only compliance but the expectation of competitive pricing. Transparency is key to managing expectations and having clear visibility to the depth and breadth of your contract agreement. Staying competitive and profitable means utilizing price guidance and price optimization when preparing to negotiate your collaboration.
How do you handle this throughout your teams? If you want sustainable growth in this ever-increasing collaboration model, you must prepare to eliminate legacy siloed processes in favor of one single source of truth that can provide the transparency, visibility and data you need to grow with the fierce competition you face.
Predications estimate that CMO market value will reach $205 billion by the year 2027
The contract manufacturing organizations (CMO) or contract development manufacturing organizations (CDMO) market is on the rise due to increasing drug R&D costs.
As a means to remaining competitive and optimizing the “total cost of ownership” associated with developing, manufacturing and commercialization of products, these companies focus on not just the function but also the value of outsourced partnerships and strategic collaborations. If you’re one of them, you have a great deal to manage.
The most significant determinant in the move to a CMO/CDMO collaboration is the need by pharma to direct their priorities toward their core areas of competency and outsource to a CMO for expertise, resources and technology in production capability and regulatory requirements.
When it comes to managing these collaborations, you must keep in mind that both partners need to strategize and manage not only compliance but the expectation of competitive pricing. Transparency is key to managing expectations and having clear visibility to the depth and breadth of your contract agreement. Staying competitive and profitable means utilizing price guidance and price optimization when preparing to negotiate your collaboration.
How do you handle this throughout your teams? If you want sustainable growth in this ever-increasing collaboration model, you must prepare to eliminate legacy siloed processes in favor of one single source of truth that can provide the transparency, visibility and data you need to grow with the fierce competition you face.
Predications estimate that CMO market value will reach $205 billion by the year 2027
REVENUE
MANAGEMENT
The path
to the peak
What is revenue
management?
The umbrella
for all trends
Climbing the
peak has its perks
Pursuit of a
common goal
STRATEGIC
COLLABORATION
Partnerships
are pivotal
Shifting from M&A
to collaboration
CMO: A
rising star
The importance
of royalties
Emerging IP
agreements
Growing complexity
in royalty models
EMERGING
PRICING MODELS
In Life Sciences,
results really do matter
Bringing together
outcomes and value
Data is the
new currency
Data and detail
make the process
GROSS-TO-NET
ACCRUALS
A clear path to
GTN visibility
Why are GTN accruals
so important?
Manage GTN
accruals
Not a different result
with the same process
Integrating
contracts with GTN
DATA SCIENCE
& ANALYTICS
360°
visibility
What's hiding
in your data?
From reactive
to predictive
Relationships
matter
What gets measured
gets managed
Going from
HOW to WHY